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Introduction
Complex traits and diseases, such as
body-mass index, height, diabetes, heart
disease, and psychiatric disorders are
undoubtedly caused by multiple genetic
and environmental factors, although it has
been a major challenge to identify specific
genes. Recently, genome-wide association
studies (GWAS) have resulted in the
detection of many robustly associated
single nucleotide polymorphism (SNP)
variants across a range of outcomes [1],
although for any particular disease or trait
the SNP variants detected explain only a
fraction of the total genetic variance
calculated from family studies. The gap
between the two has been termed the
‘‘missing heritability’’ [2,3]. Many reasons
for the missing heritability have been given
[3]. One plausible explanation is that rare
variants, which existing GWAS platforms
are not designed to capture, make signif-
icant contributions to the heritability of
many traits and diseases. It is indeed likely
that many multifactorial and heteroge-
neous phenotypes will be influenced by a
diverse array of genetic factors that span
the spectrum from private mutation to
common variant. Dickson and colleagues
[4,5] recently took a step further, by
arguing that rare variants might explain
not only some of the heritability that is
currently missing, but also that they may
be the cause of a proportion of detected
associations between complex traits and
common SNPs from GWAS. Based on
computer simulations, they proposed that
some constellations of variants within a
narrow frequency and effect size range can
account for ‘‘many’’ of the observed
associations between complex traits and
common SNPs from GWAS. This is a
strong claim and one that they say has
important implications for the ‘‘design of
future studies to detect causal variants.’’ It
is of great importance to the research
community to establish whether ‘‘many’’
represents an important proportion of
GWAS results to date, since indeed this
can impact on decisions of experimental
design and allocation of research funds.
Dickson et al. define synthetic association as
the association of a genotyped common
marker resulting from multiple unobserved
low-frequencycausalvariants(seeFigure1).
The variance contributed by the causal
variants would be much higher than
variance explained by the associated geno-
typed SNP, because the genotyped SNPs
will not‘‘tag’’(see Box 1)the causalvariants
with great precision, thus leading to the
‘‘missing’’ heritability from GWAS. Impor-
tantly, synthetic associations may arise
many hundreds of kilobases (kb) from the
site of the causal variant(s), which would
hamper attempts to locate the causal
variants responsible for association signals
by fine-mapping. Dickson et al. claim that
rare variants can give rise to synthetic
associations that are similar to many
observed GWAS associations. As we show
below, however, synthetic associations in
fact tend to differ in some important ways
to observations from GWAS. Furthermore,
even if rare variants can, in principle, give
rise to associations detectable in GWAS,
the converse proposition (that, for a given
trait, many, or even any, detected GWAS
associations arise from rare variants) does
not automatically follow.
The study of Dickson et al. [4] is the
first to consider, in detail, a genetic
architecture of multiple rare variants
within the framework of GWAS analyses.
For ease of discussion, we use the terms
rare, common, and very common alleles,
but the cut-offs between them is necessar-
ily somewhat arbitrary. For the purposes
of simulation, Dickson et al. define rare
variants as having risk allele frequency
(RAF) 0.005–0.02 and define common
SNPs to be representative of those used in
GWAS studies (minor allele frequency,
MAF.0.05). An important proportion of
GWAS associations have risk alleles in
the very common frequency spectrum
(RAF.0.3) (Figure 2a). We will show that
it is unlikely that such associations are
driven by synthetic associations with single
or multiple rare causal variants. We set out
to understand and clarify their model and
its implications in order to answer three
questions:
i) What is the expected frequency
distribution of the most associated
genotyped SNP under the Dickson et
al. model?
ii) How many loci explain total genetic
variance of complex disease under
the Dickson et al. model?
iii) Using results from the GWAS of the
International Schizophrenia Consor-
tium as an example, are the results of
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observation?
What Is the Frequency
Distribution of the Most
Associated Genotyped SNP
under the Dickson et al. Model?
The simulations of Dickson et al. (Box 1)
show that for the genetic models they
consider, SNPs with frequency typical of
those represented on GWAS panels could
tag single or multiple causal variants. They
show the likely frequency of the most
associated genotyped SNP (their Figure 5),
which provides a benchmark for compari-
sons with empirical data. To understand the
results of Dickson et al requires an under-
standing of linkage disequilibrium (Box 2)
betweenrareandcommonvariants.Wefirst
consider the situation of a synthetic associ-
ationresultingfromasinglecausalvariant.In
association studies, the genotyped SNP is
unlikely to be the causal variant, but how
likely is it that a GWAS reported associa-
tion, the most associated common SNP in a
region, tags rare causal variant(s)?
In Figure 3 we show the minimum fold
increase in genetic variance at a single
causal locus compared to the genetic
variance explained at a genotyped locus
with a given RAF, for causal variants with
allele frequencies of 0.005–0.05; the rela-
tionship is 1/r
2 (where r
2 is a measure of
LD between the variants, see Box 2). The
maximum r
2 (see Box 2) between a rare
causal variant and SNPs typically included
on GWAS chips is very low (Table 1). For
example, when the frequency of an
associated SNP allele is in the range of
0.2 to 0.5, the variation contributed by a
causal variant of frequency 0.01 is at least
25 to 100 times larger than that detected
at the genotyped SNP. In case-control
Figure 1. LD between causal and genotyped SNPs and synthetic association. SNPs 1–10 are independent SNPs in a short chromosomal
region, with population frequencies indicated by the values in the box. Rare mutations tend to be younger than common mutations. A mutation
event in the region creates causal variant C1. C1 has a higher probability of arising on the major allele (dark) of any SNP than the minor allele (light).
However, in the absence of recombination, the highest associated SNP will be the one where C1 is coupled (see Box 2) with the SNP allele of lowest
frequency, SNP 3; recombination between the SNP and the causal variant could break down this synthetic association. An independent mutation
event in the region gives rise to a second causal SNP, C2. Again C2 has higher probability of arising on the major allele of each SNP. If C2 had been the
only mutation in the region then SNP 10 would be the most highly associated, as the coupled allele has lowest frequency. However, when both
events arise in the same region, the associations at SNPs 3 and 10 are partially masked as they carry risk variants on both their alleles. C1 and C2 arise
on the same background allele for many SNPs, but SNP 8 has the allele of lowest frequency that harbours both risk alleles. In the absence of
recombination, and depending on effect size, the highest association might be with SNP 8, rather than SNPs 3 or 10. Individuals are very unlikely to
carry both C1 and C2. As more causal variants arise in the region, the most associated SNP will be the one with a detectable difference in the
contribution to risk from the risk alleles harboured on each allele. Other representations of synthetic association could be viewed in parallel with this
representation [4,5,16].
doi:10.1371/journal.pbio.1000579.g001
Box 1. The Dickson et al. Genetic Model and Simulations.
Dickson et al. [4] used coalescence theory (Box 2) [19] to simulate patterns of LD that are consistent with an evolutionary
process, and then mimicked a GWAS by simulating cases and controls and performing association with disease status and
common tagging SNPs (MAF.0.05). Specifically, each simulation was of a genomic region of length 100 kb (representing on 1/
30,000
th of the genome). To generate realistic patterns of SNP frequencies they assumed an effective population size of 10,000
and a mutation rate of 10
28. Within a 100 kb region up to 9 causal SNPs, each with frequency between 0.005 and 0.02 were
allocated to influence disease (causal SNPs). Therefore, at a locus with 9 such variants, ,20% of the general population would
be expected to carry at least one disease risk allele. The baseline probability of disease was 1% or 10%, and each risk variant had
the same increased risk for disease (genotype relative risk, GRR, see Box 3) compared to the baseline. Each simulation generated
10,000 haplotypes of the 100 kb region. Individuals in the population were simulated by sampling, with replacement, pairs of
haplotypes; these were allocated case or control status based on the probability of disease associated with the number or risk
loci they carried (with GRR combining multiplicatively when an individual carried multiple risk alleles—this is not a common
event, only about 1% of individuals will carry more than one risk allele when there are 9 causal SNPs in the 100 kb region). A
case control study was simulated by selecting equal numbers of cases and controls. The simulations varied three parameters –
the number of causal SNPs (1,3,5,7,9), the sample size of the case control study (2,000, 4,000, 6,000) and the GRR associated with
each risk allele (2,3,4,5,6). Most simulations were conducted in the absence of recombination. The more realistic scenario of
recombination (comparing different rates) was considered only when GRR=4. The simulation of recombination divided the
100 kb region into 200 fragments of 500 bp with no recombination within, and only recombination between, segments.
Additional simulations also considered 9 causal variants of GRR=4 in a 10 Mb region and recombination of 1 cM/Mb.
PLoS Biology | www.plosbiology.org 2 January 2011 | Volume 9 | Issue 1 | e1000579Figure 2. Frequency distributions of a) the risk allele frequency of the most associated SNPs listed in the GWAS Catalog [1] for the
diseases in Table 3. b) MAF of all SNPs simulated under the coalescence model, c) MAF of SNPs used in analyses to be representative of SNPs
included in GWAS. d–f) Coupled allele of most associated SNP from simulations of 1, 9, or 36 causal variants in a 100 kb region.
doi:10.1371/journal.pbio.1000579.g002
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the causal variant that would be needed to
generate the odds ratio detected at the
genotyped SNP, which depends on the
allele frequencies at the two loci (see Box
3). When the frequency of an associated
SNP allele is in the range of 0.2 to 0.5, a
detected OR of 1.1 implies that a causal
variant of frequency 0.01 must have OR 3
to 6 and a detected OR of 1.3 implies an
OR at a causal locus of 4 to 16 (Table 2).
As noted by Dickson et al., such effect sizes
would be detectable in linkage studies of
large pedigrees, or of multiple smaller
pedigrees if multiple rare variants occur at
the same chromosomal locus and so
presumably would have been found al-
ready. Therefore, if each GWAS associat-
ed SNP represented a synthetic association
with a single causal variant then, for some
traits, we would have already explained
the heritability several times over. But
what about synthetic associations caused
by multiple rare variants?
Dickson et al. [4] consider up to nine
rare causal variants within a 100 kb
genomic region. We repeated their coa-
lescent simulations (see Text S1), but using
a quantitative trait for simplicity, although
the same principles apply for disease
outcomes. For a quantitative trait the
simulated 100 kb haplotypes have quanti-
tative values which are a function of the
number of causal variants they carry, since
we assume (like Dickson et al.) that all
causal SNPs have the same effect size. We
allowed for recombination at the standard
rate of 1 cM/Mb across the whole 100 kb
region and varied the number (k) of rare
causal SNPs between 1 and 18. We
investigated the frequency distribution of
the most associated SNP allele. To make
Box 2. Glossary of Linkage Disequilibrium
We consider two loci on a chromosome. The causal locus has alleles C and c and the genotyped marker (SNP) has alleles M and
m. These alleles have frequencies pC,1 2pC,p M,12pM. The loci can make four possible haplotypes CM, cM, Cm, cm with
frequencies pCM,p Cg,p cM,p cm
Linkage Equilibrium – When the frequencies of haplotypes are the frequencies expected from the random association of the
alleles , e.g., pCM=p C pM
Linkage disequilbrium (LD) – The non-random association between alleles on a chromosome, e.g., pCM .pC pM.
Recombination breaks down linkage disequilbrium.
Recombination – Chromosomal cross-over between the paired chromosomes during meiosis so that the chromosomes
passed to offspring comprise a mixture of the chromosomes inherited from its two parents. If the cross-over event occurs
between loci C and M, then the LD between them is broken down in the transmitted chromosome. It may take several
generations or multiple recombination events to have a substantial impact on the LD in the population.
Coupled alleles – Alleles at two loci that tend to be found together on a chromosome. For example, a locus with one rare
allele (rare allele C, common allele c), will usually only make three chromosomal haplotypes with any other locus (Minor allele M,
major allele m): CM, cM,cm. In this example, the rare allele C is only found in the population coupled with the allele M. This is
called complete LD. Recombination breaks down the coupling of alleles, so that all four haplotypes exist in the population.
However, while there is linkage disequilibrium the coupled alleles are those making combinations of haplotypes with frequency
greater than expected if there was linkage equilibrium.
Measures of LD –The two commonly used measures of LD are r
2 and |D’|, both scale the covariance between the loci,
D=pCM2pC pG, but in different ways. r
2=D
2/(pC pM (12pC)(12pM)), so r is the correlation between the loci, which scales D by
the standard deviation of allelic frequency at the two loci. When pC , pM and C and M are coupled and |D’|= D/pC(1-pM), so that
D is scaled by the maximum allelic association possible given the allele frequencies at the two loci. Rare variants often make
only three haplotypes with common SNPs, in this case r
2 can be close to zero while |D’|=1.
Perfect LD – When the alleles at one locus (C and c) have the same frequency as the alleles at another locus (M and m) and
when the alleles are perfectly coupled so that only two haplotypes exist CM and cm. In this case r
2=|D’|=1.
Complete LD – When the alleles at one locus (C and c) have different frequency from the alleles at another locus (M and m),
but alleles from the C and M locus are coupled as much as is possible given the different alleles frequencies. In this case, only
three haplotypes exist in the population e.g., CM,cM,cm. In this case |D’|= 1 and r
2 can range from very close to zero to 1 (when
r
2=1, the allele frequencies of the two loci are equal and there is perfect LD). The value of r
2 depends on the allele frequency
difference between the two loci.
Maximum r
2 – The maximum r
2 possible between two loci given their allele frequencies occurs when the two loci make only
three haplotypes so that there is complete LD. If C has the lowest frequency out of C, c, M and m and if allele C is coupled with
allele M where M might be either the minor or major allele at this locus then the difference in allele frequencies between the
couple loci is v = pM 2pC. The maximum r
2 between them is r2
max~pc 1{pc{v ðÞ = 1{pc ðÞ pczv ðÞ [20]. If allele C is very rare then
r2
max&pc 1{pM ðÞ =pM, and when pM is close to 0.5, r2
max*pc.
Tagging – When a genotyped SNP that is in LD with a non-genotyped variant, the genotyped SNP tags the non-genotyped
variant.
Coalescence theory – A population genetics model of inheritance relationships among alleles at a given locus. The
coalescence of two alleles is the most recent point (going back in time) at which they shared a common ancestor. Simulation
under coalescence theory is an efficient way to generate a realistic distribution of SNP frequencies and LD between them.
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GWAS studies, we retained all SNPs with
MAF.0.2 and a proportion of SNPs of
lower MAF to generate an approximately
uniform distribution of genotyped SNPs
(Figure 2b–c). As the number of causal
SNPs increased we found that the fre-
quency of the most associated common
variant changed, based on the most likely
coupling pattern. When k=1, as discussed
above, out of all common SNPs segregat-
ing in the population, the genotyped SNP
which tags the most variance from the
causal SNP (i.e., has the highest r
2) is the
SNP with the lowest MAF in which the
minor allele is coupled with the rare causal
variant. When k.1, the genotyped SNP
which explains the highest proportion of
variance (R
2) of the quantitative trait is a
SNP where one of its alleles is coupled
with more rare variants than the other
allele. The highest R
2 across all SNPs
segregating in the population will occur for
the SNP with the lowest allele frequency
that fulfils this criterion. From the simula-
tions, the mean frequency of the most
associated genotyped SNP allele was 0.13
for one rare variant and ,0.3 for up to 18
rare variants with a trend that the
frequency of the most associated allele
increased with more rare variants in the
region. This is consistent with a slight
trend towards the observed lower R
2
between composite value of the k causal
variants and the common SNP allele for
increasing k, implying a lower power of
detection of synthetic associations with
higher RAF. Histograms of the frequen-
cies of the allele coupled with the most
number of risk variants of SNP that
generates the highest R
2 for k=1, 9, and
18 (Figure 2d–f); these distributions are
quite different from that observed from
GWAS results (Figure 2a). Of course, if a
region harbours 9 rare variants of fre-
quency 0.01, about 20% of the population
are expected to carry at least one of them.
If the true genetic architecture of a region
was one of many rare variants, then the
effect sizes necessarily attributable to each
of them must be small, otherwise the
region would have been unambiguously
identified in linkage studies and would
explain a large proportion of genetic
variation in the population.
From our simulations, we also made
some important novel observations. We
found that the total variance in haplotypes
for k causal variants was approximately k
times the variance explained by 1 causal
variant, implying that within a 100 kb
block with mutations arising randomly
and allowing for recombination at the
usual rate of 1cM/Mb that the causal
variants were in approximate linkage
equilibrium. We found that the mean R
2
between haplotype values and the pres-
ence/absence of a genotyped SNP allele
for the most associated genotyped SNP
was ,0.09 for 1 rare causal variant and
,0.08 for 9 rare variants or more. In
other words, for this particular model, the
proportion of variance attributable to the
causal variants explained by the most
associated genotyped SNP was insensitive
to the number of rare variants simulated,
so that on average the most associated
SNP explains less than 10% of the genetic
variation contributed by the locus. Fur-
thermore, we found that compared to this
average, very common associated SNPs
explained a smaller proportion of the total
variance than less common variants,
implying that the variance explained by
the causal variants would have to be very
high for such very common alleles to have
been detected given the power of typical
GWAS to date. As noted by Dickson et al.,
as sample sizes increase the power to
detect variants including synthetic associ-
ations increases, but in all cases we would
expect to see the distribution of RAF
skewed towards less common variants.
Since the distribution of the frequency of
the most associated allele observed from
GWAS is not consistent with an important
contribution of multiple rare variants and
since the variance attributable to the causal
locus would have to be unrealistically high
to be detectable by GWAS conducted to
date, we conclude that multiple rare
variants are unlikely to explain an impor-
tant proportion of GWAS results, particu-
larly for associations with very common
alleles. GWAS of larger sample size will
undoubtedly identify more associations and
will point to additional regions in the
genome for follow-up studies. A recent
GWAS of height of .180,000 individuals
[6] has identified 180 loci enriched for
genes that are connected in biological
pathways and that underlie skeletal growth
defects. Much larger sample sizes are
needed for GWAS of disease than have
been currently conducted to achieve the
same power afforded to the height study
(e.g.,,50,000casesand 50,000controlsfor
schizophrenia [7]).
How Many Loci Explain Total
Genetic Variance of Complex
Disease under the Dickson et al.
Model?
The simulations of Dickson et al. (Box 1)
are parameterised in terms of the GRR
Figure 3. Minimum fold increase in
genetic variance at single rare causal
locus given the frequency of the risk
allele at the genotyped associated lo-
cus. The minimum fold increase is calculated
as 1/r
2, with r
2 calculated as the maximum r
2
given the frequency of the trait increasing
allele at the genotyped SNP and the frequen-
cy of the causal allele (see Box 2).
doi:10.1371/journal.pbio.1000579.g003
Table 1. Maximum r
2 possible between a rare causal variant and a genotyped SNP, which occurs when the rare causal variant is
coupled with the minor allele of the genotyped SNP (see Box 2).
Freq of causal variant (p
C) Freq of genotyped SNP (pM)
0.05 0.10 0.20 0.30 0.40 0.50
0.005 0.10 0.05 0.02 0.01 0.01 0.01
0.01 0.19 0.09 0.04 0.02 0.02 0.01
0.02 0.39 0.18 0.08 0.05 0.03 0.02
The frequencies of the causal variants listed reflect the minimum, approximate mean and maximum considered by Dickson et al.
doi:10.1371/journal.pbio.1000579.t001
PLoS Biology | www.plosbiology.org 5 January 2011 | Volume 9 | Issue 1 | e1000579(genotype relative risk, Box 3) of the causal
variants. They consider a range of effect
sizes (GRR 2–6) for each of the causal
variants and GWAS case-control samples
of 2,000 to 6,000. Although such simula-
tions allow evaluation of the ability to
detect synthetic associations and allow
extrapolation to smaller effect sizes and
larger sample sizes, the results generated
from the selected parameters do have an
impact on the perception of the impor-
tance of synthetic associations. To inter-
pret the genetic architecture of their model
we calculated the variance explained
under the liability threshold model (see
Box 3), assuming that each causal variant
has frequency 0.01 (the average of the
range considered, which will make our
results conservative since the distribution
of variance explained for causal variants of
frequency 0.005–0.02 is not symmetric).
When baseline disease probability was
0.01, a single GRR of 2 corresponds to a
variant explaining 0.15% of the variance
in liability and a GRR of 6 corresponds to
1.2% of the variance in liability. For 9
causal variants the variance explained is
approximately 9 times the value for a
single locus, i.e., 1.4% for GRR=2 and
13% for GRR=6. Table 4 shows how the
probability of disease in the population
increases under the Dickson et al. model,
which fixes the baseline (no risk alleles)
probability of disease; for the model with
baseline probability of disease of 10% for 9
causal variants each of GRR=6, the
actual probability of disease in the popu-
lation is 19%. For more natural bench-
marking, we have undertaken the calcula-
Table 2. Expected odds ratio at a single causal variant given observed odds ratio of 1.1 at the genotyped SNP (see Box 3).
Freq of causal variant (p
C) Freq of genotyped SNP (pM)
0.05 0.10 0.20 0.30 0.40 0.50
0.005 2.0 3.0 5.0 7.0 9.0 11.0
0.01 1.5 2.0 3.0 4.0 5.0 6.0
0.02 1.3 1.5 2.0 2.5 3.0 3.5
The frequencies of the causal variants listed reflect the minimum, approximate mean and maximum considered by Dickson et al.
doi:10.1371/journal.pbio.1000579.t002
Box 3. Glossary of Terms Underlying Variance Explained by a Locus on the Liability Scale
We assume a single locus with two alleles, the non-risk allele, c and the risk allele, C. The frequency of the risk allele is p, so that
the frequency of the genotypes cc, cC and CC in the population are (12p)
2,2 p(12p) and p
2, assuming Hardy-Weinberg
equilibrium.
Genotype relative risk (GRR): GRR expresses the increased risk of disease associated with a single risk allele and is
represented by the single character c, so that under a multiplicative model of disease, the probability of disease for the three
different genotypes are P(D|cc)=Q, P(D|Cc)=Qc and P(D|CC)=Qc
2. If the disease prevalence in the population is, K and
P(D)=K=(12p)
2(D|cc)+2p(12p)P(D|Cc)+p
2P(D|CC), then Q = K/(1+p(c21))
2. For high GRR Qc
2.1, in this case P(D|CC) should
be constrained to 1, and then Q=K/(1+p(c21))
2
. Dickson et al. chose to allow disease prevalence to vary, by fixing Q as a
defined baseline probability.
Odds Ratio (OR): The OR for heterozygotes compared to homozygotes of the non-risk allele is a function of the ratios of the
probabilities of disease and not disease (ND) for the different genotype classes (P(D|Cc)/P(ND|Cc))/(P(D|cc)/P(ND|cc))=c(12Q)/
(12Qc).
Equivalence of GRR and OR: As KR0, ORRc. Since K is small for most complex genetic diseases, GRR for heterozygotes and
OR are used interchangeably. OR can be estimated from data as it is robust to the inflated P(D) in case control studies—i.e.,
where the frequency of cases is often ,0.5, rather than K.
Variance explained on the liability scale: If the associated variant has effect size GRR and allele frequency p, then the
genetic variance in liability explained by the variant can be calculated from the mean liability associated with each genotype
class (Table 4), but can be approximated as VG=2p(12p)ln(OR)
2/i
2, where i is the mean liability (expressed in standard deviation
units) of the diseased group calculated from normal distribution theory assuming a disease prevalence, K. i=z/p, where z the
height of the standard normal curve at the liability (T) that truncates the proportion K on the standard normal curve. The
residual variance is assumed to be normally distributed with variance 1, so the variance explained by the locus on the liability
scale is h
2=VG/(1+VG). The assumptions of normality used in the liability threshold model break down when each rare locus
contributes a large proportion of the variance.
Variance explained at causal versus marker loci: If the variance in disease liability explained by a causal locus is VC, then
the variance explained at the genotyped locus is VM=r
2VC (where r
2is the linkage disequilibrium described in Box 2). Therefore,
if we estimate the variance explained by a common genotyped genetic marker, VM then we can estimate the variance explained
by the causal variant is expected to be VC=VM/r
2. This relationship holds for quantitative traits but breaks down for disease
traits when VM2VC is large and so cannot be used for calculating the variance explained by the causal variant. Instead we
calculate the odds ratio at the causal locus and calculate the variance explained from that.
OR at the causal locus given the estimate of the OR at the genotyped SNP: The OR at the causal locus ORC can be
calculated as a function of the OR at the genotyped locus, ORC=1+(OR21)pM/pC [21].
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population. Assuming a disease with a
heritability of 0.8, we calculate the max-
imum number of these 100 kb loci possi-
ble in the genome if all the genetic liability
variance were attributable to loci like this,
as this provides an upper limit to the
contribution of such loci. The maximum
number of loci can be high (maximum
543, with 543 100 kb blocks representing
,2% of the genome) when there is only a
single causal variant of GRR=2 within a
100 kb region; we showed in the previous
section that very common genotyped
SNPs are unlikely to ever be the most
associated SNP from a GWAS tagging
single rare causal variants. When there are
9 causal variants, the maximum number of
100 kb regions required to explain all the
variance for the models considered by
Dickson et al. is only 59 (,0.2% of the
genome), occurring when the GRR of
each causal variant is 2 so that each block
explains 1.4% of the variance. Dickson et
al. showed that if 9 causal variants were
segregating in a 10 Mb block that the most
associated SNP may be positioned several
Mb from the most distal causal variant it is
coupled with. Even if associations from
causal variants spanned several Mb for
synthetic associations, to have an impor-
tant contribution to disease variance we
would expect to see associations concen-
trated in only a fraction of the genome.
This will be a testable hypothesis as sample
sizes increase; results to date do not
support such a concentration of associa-
tions. Since the simulation parameters
used by Dickson et al. generate a relatively
small number of rather large loci, their
results may generate a false sense of the
relative importance of the contribution of
synthetic associations to GWAS results
observed to date.
Using Results from the GWAS of
the International Schizophrenia
Consortium as an Example, Are
the Results of Dickson et al.
Supported by Empirical
Observation?
In 2009, the International Schizophre-
nia Consortium (ISC) reported an analysis
that supported a genetic model for schizo-
phrenia that included a substantial num-
ber of common variants of small effect.
Dickson et al. claimed, of the ISC analysis,
that multiple rare variants in a region are
capable of acting over large distances to
create associations in common variants
similar to those observed by the ISC.
However, as we have shown above, a
genetic architecture dominated by rare
causal variants leads to a distribution of
risk alleles of detected associations skewed
to low frequencies, which is not consistent
with the ISC data, as we show below.
Schizophrenia is a common complex
disease for which several studies [8,9,10,11]
(including one by the ISC) have identified a
role for very rare structural variants in its
underlying genetic architecture. In a GWAS
comprising of 3,322 cases and 3,587 controls
[12], the ISC analysis presented evidence
that some common genetic variants also
contribute to the genetic architecture, dem-
onstrated by the highly significant signal of
association of in an independent case-
control sample based on a profile of the
top 50% of associated SNPs from the ISC
study. In the ISC study we undertook
simulations of a wide range of genetic
architectures in which we varied allele
frequency, effect size distributions and the
extent of LD between causal and genotyped
SNPs. Although we could reject many of the
simulated genetic architectures as not being
representative of the observed results, many
others were consistent with our results, but
all consistent models included common
variants as well as rare causal variants.
Dickson et al. cites the ISC paper and
specifically implied that multiple rare vari-
ants could explain the ISC results. Since our
only conclusion was that the genetic archi-
tecture must include common variants (we
specificallystated ‘‘our results do not exclude
important contributions of rare variants for
schizophrenia’’), their statement must be
interpreted that they believe a model
without common variants could explain
the ISC results. Within the ISC GWAS
analysis we specifically investigated whether
a rare variants-only model could fit the
observed distribution of the frequencies of
associated variants. Those results corrobo-
rate the results from the coalescent simula-
tions we have undertaken here, namely that
a rare variants-only model predicts a skewed
distribution of associations for risk alleles of
low frequencies. While, as noted in the ISC
paper, we did observe an enrichment of
associations with lower-frequency common
alleles, we did not observe the substantial
excess predicted by a rare variants-only
model. Using exactly the same coalescent
simulation models and methods as Dickson
et al., we repeated the polygenic analysis
presented by the ISC. For comparability
with the ISC analyses, we sampled variants
from the full simulated set to obtain a MAF
distribution similar to that observed in the
ISC GWAS, and we further restricted
analysis to an LD pruned set (no pairwise
LD r
2.0.25). Using the same discovery/
sample framework described in [12], we
stratified variants into quintiles according to
the frequency of the risk-increasing allele. In
contrast to the results for the observed ISC
data (Figure 4a, following Figure 4a of [12]),
the results from simulations under Dickson
et al.’s model (Figure 4b) show a marked
skewing towards the lower quintiles, indi-
cating that lower frequency SNPs on the
GWAS platforms do a better job at tagging
rare variants than more common SNPs.
Therefore, the empirical results from the
ISC GWAS are not consistent with the
model presented by Dickson et al. being a
general explanation of common variant
association.
In our simulations, as in those of
Dickson et al., we observed genome-wide
significant results a good proportion of the
time (90% for loci with 9 causal variants
with GRR=4), suggesting that if variants
of this effect size and frequency ,0.01
exist (the benchmark simulations of Dick-
son et al.) then they would have been
detected by standard single SNP analysis
in the ISC GWAS. It is important to note
that this ability is achieved using standard
GWAS chips, which are designed to have
a biased distribution of allele frequencies
(higher proportion of common variants)
relative to the distribution of SNP allele
frequencies in the population (and the
distribution of SNP frequencies generated
by the coalescent simulations).
Conclusion
Under evolutionary theory we expect a
genetic architecture of many more rare
than common variants and a negative
correlation between effect size and MAF
[13,14]. Lessons learned from Mendelian
disorders lead us to expect that genes
involved in the genetic architecture of
disease will harbour many causal variants
[15]. In association studies it is well
recognised that genotyped SNPs tag other,
unobserved, variants in the genome and
that when a SNP is identified as associated
it is unlikely that the SNP itself is the
causal variant. Whether synthetic associa-
tions with rare causal variants represent a
significant proportion of associations de-
tected in GWAS depends on the true, but
mostly unknown, genetic architecture.
Dickson et al. [4] used simulation to
determine if associations detected in
GWAS could reflect synthetic associations
of single or multiple rare causal variants.
Their abstract states, ‘‘We show that they
are not only possible, but inevitable, and
that under simple but reasonable genetic
models, they are likely to account for or
contribute to many of the recently identi-
fied signals reported in genome-wide
association studies.’’ Their results have
PLoS Biology | www.plosbiology.org 7 January 2011 | Volume 9 | Issue 1 | e1000579Figure 4. Polygenic analyses following the International Schizophrenia Consortium [12]. a) The original results for polygenic score
analysis in the ISC, when stratified by quintile of risk-increasing allele frequency (Q1 being the lowest risk-increasing allele frequency, Q5 the most
common; the range is between 0.02 and 0.98). b) We repeated these analyses on simulated data, generated under a ‘‘rare variant only’’ model and
using the same simulation procedure as Dickson et al., assuming that risk loci harbor 9 causal variants, GRR=4, MAF 0.005–0.02). The pile-up of signal
in the lower quintiles, which is expected under Dickson et al.’s model, is clearly not consistent with the observed ISC results. In the simulations, SNPs
are generated through a coalescent process; a subset of SNPs is selected as ‘‘genotyped’’ to represent the marker density, frequency distribution and
LD profile observed in the original ISC study (which has properties that are typical of most GWAS, including the under-representation of low
frequency variants). The y axis is the –log10P from the logistic regression of case-control status on profile score in an independent ‘‘target’’ case-
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nity to imply that this mechanism could
apply to an important proportion of
associations detected in GWAS. Bench-
marking the importance of synthetic
associations with rare causal variants is
relevant for determining the direction of
future research.
The relevance of the simulations con-
ducted by Dickson et al. depends on
whether the genetic architecture they
assumed is a realistic representation of
nature. Empirical observations do not
generate the pattern of results generated
by their genetic model, which implies that
their model applied genome-wide does not
reflect the typical architecture of complex
disease. If their model of genetic architec-
ture is only representative of a small
proportion of the genome and represents
only a small proportion of the genetic
variance, their results cannot be represen-
tative of most GWAS results. A genetic
architecture of rare variants only will
generate a distribution of associated vari-
ants very heavily skewed towards geno-
typed SNPs with low RAF; this does not
agree with observation. Multiple rare
variants within short genomic regions
could generate associations with alleles of
higher frequency including major alleles,
but the variance explained by the causal
variants would need to be so high that
firstly, it should have been detected by
linkage studies and, secondly, it would
imply very few such loci across the genome
for the mechanism to be considered
important. Results from GWAS suggest
that associations are not concentrated in a
handful of locations and show that high
frequency alleles have been reported for
most diseases (Table 3).
Undoubtedly, part of the missing heri-
tability is explained by imperfect LD
between the genotyped SNPs and causal
variants, including rare causal variants and
including multiple rare causal variants
concentrated in relatively short genomic
regions. Dickson and colleagues [4,5] give
six examples of known synthetic associa-
tions detectable in GWAS but generated
by rare causal variants, providing compel-
ling evidence for their existence. However,
their examples likely represent the high
end of effect size of rare causal variants
(since in many instances the causal vari-
ants had been detected in the pre-GWAS
era) and yet, in all examples, the RAF of
the most associated tag SNPs (13 were
listed across the examples) were less than
0.33. However, the majority of associa-
tions detected from GWAS are for very
common SNPs (Table 3); although very
common associated SNPs are not likely to
be the causal variants, they are much more
likely to tag causal variants of similar
frequency and highly unlikely to represent
synthetic associations with single or mul-
tiple rare causal variants. Thus, we
conclude that synthetic associations creat-
ed by rare variants are unlikely to explain
the majority of GWAS results. That is,
because multiple rare variants can create
synthetic associations (as nicely shown by
Dickson et al.), it doesn’t follow that
observed associations with common SNPs
are caused by multiple rare variants.
Orozco et al. [16], reviewing empirical
and theoretical data, and drawing partic-
ularly upon evidence from linkage studies,
pathway analyses and trans-ethnic studies,
also recently concluded that synthetic
associations with multiple rare variants
cannot be responsible for many reported
GWAS associations. The synthetic associ-
ation hypothesis was also specifically
addressed in a recent multi-ethnic study.
Waters et al. [17] took 19 variants (15 had
RAF.0.3) reproducibly associated to
Type 2 Diabetes in Europeans and tested
them in 5 racial/ethnic groups (European
Americans, African Americans, Latinos,
Japanese Americans, and Native Ameri-
cans). Despite the relatively small sample
size for what was essentially a replication
study (total size of 14,000 across all groups)
the OR for total number of risk alleles in
each ethnic group was highly significant,
implying ancient causal variants predating
the migrations that separated these popu-
lations. Waters et al. argued that synthetic
associations with rare variants could not
explain these common associations with
Type 2 diabetes.
Empirical observation suggests that
much of the missing heritability is con-
tributed by causal variants (including loci
comprising multiple rare variants) having
effect size too small to be detected with
stringent statistical significance [6,12,18].
Larger samples for GWAS are needed to
control sample using a score calculated as the number of alleles identified as associated (with p-value less than a threshold pT) in the discovery case-
control sample association analysis, scaled within each figure as so that the maximum value observed for five significance thresholds (pT=0.1, 0.2, 0.3,
0.4, and 0.5, plotted left to right in each quintile) is scaled to 1 and the minimum is scaled to zero.
doi:10.1371/journal.pbio.1000579.g004
Table 3. Associations of SNPs with very common SNP alleles detected in GWAS
associations downloaded from the GWAS Catalog [1].
Disease
No. SNPs with
associations
a
Proportion of
associations
For RAF . 0.3
Proportion of
associations
For RAF . 0.8
Asthma 11 0.73 0.18
Ankylosing Spondylitis 8 0.88 0.13
Age Related Macular Degeneration 11 0.64 0.09
Bipolar Disorder 42 0.57 0.07
Breast Cancer 19 0.53 0.05
Celiac Disease 40 0.60 0.08
Chronic Kidney Disease 28 0.54 0.00
Coronary Heart Disease 13 0.69 0.15
Crohn’s Disease 37 0.64 0.03
Multiple Sclerosis 33 0.64 0.09
Pancreatic Cancer 19 0.68 0.05
Parkinson’s Disease 10 0.80 0.40
Prostate Cancer 27 0.62 0.07
Type 1 Diabetes 41 0.73 0.10
Type 2 Diabetes 28 0.64 0.11
Schizophrenia 17 0.47 0.12
Systemic lupus erythematosus 29 0.31 0.03
SNPs are included in the catalog for GWAS of .100,000 SNPs, SNP p-value ,10
25 in the overall (initial GWAS
+ replication) population or SNP p-value ,10
25 when there is no replication stage. To avoid duplications, if
the chromosomal cytogenetic band region contained .1 associated SNP, the one with the lowest RAF was
selected.
doi:10.1371/journal.pbio.1000579.t003
PLoS Biology | www.plosbiology.org 9 January 2011 | Volume 9 | Issue 1 | e1000579detect these which would directly compete
with research funds used in sequencing
studies. Our assessment is that that the
importance of synthetic associations gen-
erated by multiple variants has been
overstated. Sample sizes of about 50,000
cases and 50,000 controls are required for
a GWAS of schizophrenia [7] to afford the
same power in detection of variance
explained as a GWAS of 180,000 individ-
uals for height [6]. The height study found
that in 13 of 21 loci containing a known
skeletal growth gene, the known gene was
closest to the most associated variant in the
region, leading the authors to make the
general conclusion that the likely causal
gene is often located near the most
strongly associated variant [6]. Genes
identified through GWAS harbouring
common variants are likely to be good
targets for identification of rare variants
and for sorting the wheat from the chaff in
next generation sequencing studies. We
expect that continued GWAS will make
valuable contributions to our understand-
ing of many complex traits and will, for
some time, remain as one important tool
in a growing set of technologies to probe
the full spectrum of genetic variation
efficiently.
Supporting Information
Text S1 Supplementary Informa-
tion
Found at: doi:10.1371/journal.pbio.
1000579.s001 (0.03 MB DOC)
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